Genetic Signatures Limited (GSS.AX)

AUD 0.39

(2.67%)

Gross Profit Summary of Genetic Signatures Limited

Genetic Signatures Limited's latest annual gross profit in 2024 was -16.2 Million AUD , down -27.18% from previous year.
Genetic Signatures Limited's latest quarterly gross profit in 2024 FY was -16.2 Million AUD , down -27.18% from previous quarter.
Genetic Signatures Limited reported a annual gross profit of -12.73 Million AUD in annual gross profit 2023, down -276.64% from previous year.
Genetic Signatures Limited reported a annual gross profit of 7.21 Million AUD in annual gross profit 2022, up 68.9% from previous year.
Genetic Signatures Limited reported a quarterly gross profit of -9.44 Million AUD for 2024 Q2, down 0.0% from previous quarter.
Genetic Signatures Limited reported a quarterly gross profit of -7.07 Million AUD for 2024 Q4, down 0.0% from previous quarter.

Annual Gross Profit Chart of Genetic Signatures Limited (2024 - 2013)

Historical Annual Gross Profit of Genetic Signatures Limited (2024 - 2013)

Year	Gross Profit	Gross Profit Growth
2024	-16.2 Million AUD	-27.18%
2023	-12.73 Million AUD	-276.64%
2022	7.21 Million AUD	68.9%
2021	4.27 Million AUD	280.55%
2020	-2.36 Million AUD	-156.81%
2019	4.16 Million AUD	38.26%
2018	3.01 Million AUD	28.78%
2017	2.33 Million AUD	3.93%
2016	2.24 Million AUD	247.11%
2015	648.12 Thousand AUD	-5.5%
2014	685.83 Thousand AUD	586.36%
2013	-141.01 Thousand AUD	0.0%

Year	Gross Profit	Gross Profit Growth
2024 FY	-16.2 Million AUD	-27.18%
2024 Q2	-9.44 Million AUD	0.0%
2024 Q4	-7.07 Million AUD	0.0%
2023 Q4	-8.92 Million AUD	0.0%
2023 FY	-12.73 Million AUD	-276.64%
2023 Q2	-3.81 Million AUD	0.0%
2022 Q4	370 Thousand AUD	0.0%
2022 FY	7.21 Million AUD	68.9%
2022 Q2	6.84 Million AUD	0.0%
2021 FY	4.27 Million AUD	280.55%
2021 Q4	-1.48 Million AUD	0.0%
2021 Q2	5.75 Million AUD	0.0%
2020 Q2	-2.4 Million AUD	0.0%
2020 FY	-2.36 Million AUD	-156.81%
2020 Q4	38 Thousand AUD	0.0%
2019 Q4	-1.76 Million AUD	0.0%
2019 Q2	2.01 Million AUD	0.0%
2019 FY	4.16 Million AUD	38.26%
2018 Q4	1.52 Million AUD	0.0%
2018 Q2	1.48 Million AUD	0.0%
2018 FY	3.01 Million AUD	28.78%
2017 Q2	1.2 Million AUD	0.0%
2017 FY	2.33 Million AUD	3.93%
2017 Q4	1.13 Million AUD	0.0%
2016 Q2	955.02 Thousand AUD	0.0%
2016 Q4	1.29 Million AUD	0.0%
2016 FY	2.24 Million AUD	247.11%
2015 Q2	595.27 Thousand AUD	0.0%
2015 Q4	671.12 Thousand AUD	314.2%
2015 FY	648.12 Thousand AUD	-5.5%
2015 Q3	162.03 Thousand AUD	-72.78%
2015 Q1	- AUD	0.0%
2014 FY	685.83 Thousand AUD	586.36%
2014 Q2	- AUD	0.0%
2014 Q3	- AUD	0.0%
2014 Q4	- AUD	0.0%
2013 FY	-141.01 Thousand AUD	0.0%

Peer Gross Profit Comparison of Genetic Signatures Limited

Name	Gross Profit	Gross Profit Difference
Australian Clinical Labs Limited	247.36 Million AUD	106.55%
BCAL Diagnostics Limited	3.09 Million AUD	622.934%
Genetic Technologies Limited	3.9 Million AUD	514.934%
Healius Limited	541.2 Million AUD	102.994%
Imagion Biosystems Limited	-3.88 Million AUD	-317.217%
Integral Diagnostics Limited	103.8 Million AUD	115.607%
INOVIQ Ltd	-989.82 Thousand AUD	-1536.759%
Microba Life Sciences Limited	-8.58 Million AUD	-88.774%
Monash IVF Group Limited	85.5 Million AUD	118.949%
Rhythm Biosciences Limited	-1.35 Million AUD	-1093.556%
Sonic Healthcare Limited	2.33 Billion AUD	100.695%